S
Smart4Diagnostics
Creating a digital human sample fingerprint in order to improve patient safety, preanalytical quality and lab turnaround time
About Smart4Diagnostics
Developer of a real-time monitoring platform designed to ensure the quality of blood samples. The company's platform provides a digital human blood sample fingerprint that detects and reduces pre-analytical errors at sample collection when patients are still present, optimizes work processes, and reduces laboratory costs, enabling laboratories to digitize workflow and improve turnaround time. Keywords: Pharmaceuticals and Biotechnology, Healthcare Devices / Services / Supplies, Blood Collection System, Blood Collection Tools, Blood Sample, Personalized Medicine Approach, Real Time Monitoring, Sample Fingerprinting.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Munich, Germany
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
EIT Health
UnternehmerTUM
Initiative for Industrial Innovators
Series A2 investors entered at this stage
SARSTEDT AG & Co. KG
VP Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Smart4Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Smart4Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.